Form D · Other Health Care

Respirix, Inc.

San Francisco, CA · CIK 0001764552

Offering snapshot reported Aug 13, 2019 · SEC filing

Reported sold
$1.3M
Offering amount: $1.5M
Investors reported
90
Form D · investor count
Minimum accepted
$200
Reported outside-investor minimum
First sale
Nov 24, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 13, 2019Initial$1,300,226No comparison90SEC filing

Offering details

Securities
Debt
Exemptions
06c
Duration over one year
No
Business combination
No
Sales commissions
$47.3K
Finders' fees
$0
Form D file number
021-346431
Includes $18,923.50 in dollar value of securities on the same terms as the offering issued to SI Securities, LLC as in-kind sales compensation
Includes cash and plus securities equal to 5% of the dollar-value of securities placed by SI Securities, LLC on the same terms as the offering. An additional $10,000 was received by SI Securities, LLC as reimbursement for expenses.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
SI Securities, LLC170937

Source: Form D, filed Aug 13, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Daniel Burnett Director, Executive
Eric Kriegstein Director, Executive
Evan Luxon Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
101 Mississippi St
San Francisco, CA, 94107